The histological growth patterns in liver metastases from colorectal cancer display differences in lymphoid, myeloid, and mesenchymal cells
Colorectal liver metastases grow following different histologic growth patterns (HGPs), classified as desmoplastic and nondesmoplastic (dHGP, non-dHGP), being the latter associated with worst prognosis. This study aimed to investigate the tumor microenvironment (TME) between HGPs supporting different survival. Multiplexed immunohistochemical staining was performed with the Opal7 system in a 100-patients cohort to evaluate the tumor-liver interface with three different cell panels: lymphoid, myeloid, and carcinoma-associated fibroblasts. Differences between HGPs were assessed by Mann-Whitney <i>U</i> test with Pratt correction and Holm-Bonferroni multitest adjustment. Cytotoxic T-cells were more abundant in tumoral areas of dHGP, while non-dHGP had higher macrophages infiltration, Th2, CD163<sup>+</sup>, and Calprotectin<sup>+</sup> cells as well as higher pSMAD2 expression. Regarding carcinoma-associated fibroblasts, several subsets expressing COL1A1 were enriched in dHGP, while αSMA<sup>low</sup>_single cells were present at higher densities in non-dHGP. Interestingly, Calprotectin<sup>+</sup> cells confer better prognoses in non-dHGP, identifying a subgroup of good outcome patients that unexpectedly also show an enrichment in other myeloid cells. In summary, our results illustrate different TME landscapes with respect to HGPs. dHGP presents a higher degree of immunocompetence, higher amounts of Collagen 1 as well as lesser presence of myeloid cell populations, features that might be influencing on the better prognosis of encapsulated metastases.
Authors
- Gemma Garcia‐Vicién (ORCID: https://orcid.org/0000-0002-6428-1847)
- J.C. Ruffinelli (ORCID: https://orcid.org/0000-0003-2947-320X)
- Artur Mezheyeuski (ORCID: https://orcid.org/0000-0002-4394-2634)
- Miguel Ángel Pardo (ORCID: https://orcid.org/0000-0002-3395-3380)
- Patrick Micke (ORCID: https://orcid.org/0000-0003-1210-5961)
- Laura Lladó (ORCID: https://orcid.org/0000-0002-3717-3306)
- María Bañuls
- Kristel Mils (ORCID: https://orcid.org/0000-0002-2543-4775)
- Nuria Ruíz (ORCID: https://orcid.org/0000-0002-7999-3679)
- N. Martinez Molina
- David G. Molleví (ORCID: https://orcid.org/0000-0003-1392-8070)
Institutions
- Uppsala University (SE)
- Bellvitge University Hospital (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Institut Català d'Oncologia (ES)
- Vall d'Hebron Institute of Oncology (ES)
Publication Details
- Journal
- MedComm
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1002/mco2.70000
- Citations
- 2
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Centres de Recerca de Catalunya
- Cancerfonden
- Generalitat de Catalunya
- P. O. Zetterlings stiftelse
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- European Regional Development Fund